Marius Pharmaceuticals CEO to Speak at FDA Expert Panel on Testosterone Therapy
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 04 2025
0mins
Source: Globenewswire
- Industry Milestone: Marius Pharmaceuticals CEO Shalin Shah will speak at the FDA Expert Panel on Testosterone Replacement Therapy for Men on December 10, 2025, marking a significant advancement in men's health and expected to enhance scientific discussions around testosterone therapy.
- Regulatory Shift: The FDA will open a public docket to gather questions and data related to testosterone therapy, reflecting a commitment to reevaluating long-standing misconceptions and potentially impacting treatment options for millions of men.
- Scientific Dialogue: The panel, hosted by Dr. Brian Christine, will feature Shah and other experts sharing insights on the scientific, clinical, and regulatory aspects of testosterone therapy, aiming to correct misconceptions and promote evidence-based treatment.
- Live Participation: The event will be livestreamed from 1 PM to 3 PM ET, allowing public participation for those unable to attend in person, further enhancing Marius's influence and public awareness in the men's health sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
